FR2762213B1 - Composition pharmaceutique a retention gastrique - Google Patents

Composition pharmaceutique a retention gastrique

Info

Publication number
FR2762213B1
FR2762213B1 FR9704803A FR9704803A FR2762213B1 FR 2762213 B1 FR2762213 B1 FR 2762213B1 FR 9704803 A FR9704803 A FR 9704803A FR 9704803 A FR9704803 A FR 9704803A FR 2762213 B1 FR2762213 B1 FR 2762213B1
Authority
FR
France
Prior art keywords
pharmaceutical composition
gastric retention
gastric
retention
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9704803A
Other languages
English (en)
Other versions
FR2762213A1 (fr
Inventor
Jerome Besse
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synthelabo SA
Original Assignee
Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR9704803A priority Critical patent/FR2762213B1/fr
Application filed by Synthelabo SA filed Critical Synthelabo SA
Priority to KR1019997009438A priority patent/KR20010006353A/ko
Priority to CA002286081A priority patent/CA2286081A1/fr
Priority to NZ500288A priority patent/NZ500288A/xx
Priority to CN98804269A priority patent/CN1252720A/zh
Priority to EP98920623A priority patent/EP0983065A1/fr
Priority to AU73416/98A priority patent/AU737634B2/en
Priority to PCT/FR1998/000755 priority patent/WO1998047506A1/fr
Priority to PL98336273A priority patent/PL336273A1/xx
Priority to IL13199598A priority patent/IL131995A0/xx
Priority to JP54514398A priority patent/JP2001523241A/ja
Priority to HU0002455A priority patent/HUP0002455A3/hu
Priority to TNTNSN98049A priority patent/TNSN98049A1/fr
Priority to PE1998000281A priority patent/PE68199A1/es
Priority to MA25037A priority patent/MA26482A1/fr
Priority to ARP980101773A priority patent/AR015586A1/es
Priority to ZA983258A priority patent/ZA983258B/xx
Priority to JO19982017A priority patent/JO2017B1/en
Publication of FR2762213A1 publication Critical patent/FR2762213A1/fr
Publication of FR2762213B1 publication Critical patent/FR2762213B1/fr
Application granted granted Critical
Priority to NO995039A priority patent/NO995039L/no
Priority to US09/886,991 priority patent/US20010046473A1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Nutrition Science (AREA)
  • Anesthesiology (AREA)
  • Physiology (AREA)
  • Psychology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR9704803A 1997-04-18 1997-04-18 Composition pharmaceutique a retention gastrique Expired - Fee Related FR2762213B1 (fr)

Priority Applications (20)

Application Number Priority Date Filing Date Title
FR9704803A FR2762213B1 (fr) 1997-04-18 1997-04-18 Composition pharmaceutique a retention gastrique
HU0002455A HUP0002455A3 (en) 1997-04-18 1998-04-15 Gastric-retained pharmaceutical composition
CA002286081A CA2286081A1 (fr) 1997-04-18 1998-04-15 Composition pharmaceutique a residence gastrique
NZ500288A NZ500288A (en) 1997-04-18 1998-04-15 Gastric-retained pharmaceutical composition comprising benzamide as the active principle and a carbon dioxide generating system
CN98804269A CN1252720A (zh) 1997-04-18 1998-04-15 胃停留药物组合物
EP98920623A EP0983065A1 (fr) 1997-04-18 1998-04-15 Composition pharmaceutique a residence gastrique
AU73416/98A AU737634B2 (en) 1997-04-18 1998-04-15 Pharmaceutical composition for gastric residence
PCT/FR1998/000755 WO1998047506A1 (fr) 1997-04-18 1998-04-15 Composition pharmaceutique a residence gastrique
PL98336273A PL336273A1 (en) 1997-04-18 1998-04-15 Pharmaceutic composition active in stomach portion of gastrointestinal system
IL13199598A IL131995A0 (en) 1997-04-18 1998-04-15 Gastric-retained pharmaceutical compositions
KR1019997009438A KR20010006353A (ko) 1997-04-18 1998-04-15 위 체류 약제조성물
JP54514398A JP2001523241A (ja) 1997-04-18 1998-04-15 胃滞留性医薬組成物
TNTNSN98049A TNSN98049A1 (fr) 1997-04-18 1998-04-16 Composition pharmaceutique a residence gastrique.
MA25037A MA26482A1 (fr) 1997-04-18 1998-04-17 Composition pharmaceutique a residence gastrique.
ARP980101773A AR015586A1 (es) 1997-04-18 1998-04-17 Composicion farmaceutica de residencia gastrica.
ZA983258A ZA983258B (en) 1997-04-18 1998-04-17 Pharmaceutical composition for gastric residence
PE1998000281A PE68199A1 (es) 1997-04-18 1998-04-17 Composicion farmaceutica de residencia gastrica
JO19982017A JO2017B1 (en) 1997-04-18 1998-04-18 Pharmaceutical formula for infectious residence
NO995039A NO995039L (no) 1997-04-18 1999-10-15 Gastrisk bibeholdt farmasoeytisk preparat
US09/886,991 US20010046473A1 (en) 1997-04-18 2001-06-25 Gastric-retained pharmaceutical composition and method for its use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9704803A FR2762213B1 (fr) 1997-04-18 1997-04-18 Composition pharmaceutique a retention gastrique

Publications (2)

Publication Number Publication Date
FR2762213A1 FR2762213A1 (fr) 1998-10-23
FR2762213B1 true FR2762213B1 (fr) 1999-05-14

Family

ID=9506077

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9704803A Expired - Fee Related FR2762213B1 (fr) 1997-04-18 1997-04-18 Composition pharmaceutique a retention gastrique

Country Status (19)

Country Link
EP (1) EP0983065A1 (fr)
JP (1) JP2001523241A (fr)
KR (1) KR20010006353A (fr)
CN (1) CN1252720A (fr)
AR (1) AR015586A1 (fr)
AU (1) AU737634B2 (fr)
CA (1) CA2286081A1 (fr)
FR (1) FR2762213B1 (fr)
HU (1) HUP0002455A3 (fr)
IL (1) IL131995A0 (fr)
JO (1) JO2017B1 (fr)
MA (1) MA26482A1 (fr)
NO (1) NO995039L (fr)
NZ (1) NZ500288A (fr)
PE (1) PE68199A1 (fr)
PL (1) PL336273A1 (fr)
TN (1) TNSN98049A1 (fr)
WO (1) WO1998047506A1 (fr)
ZA (1) ZA983258B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6169094B1 (en) * 1998-07-14 2001-01-02 Sanofi-Synthelabo Compositions of (S) (-)-amisulpride
FR2784583B1 (fr) 1998-10-16 2002-01-25 Synthelabo Composition pharmaceutique a residence gastrique et a liberation controlee
FR2790388B1 (fr) * 1999-03-04 2001-04-13 Synthelabo Compositions pharmaceutiques comprenant un benzamide et au moins un promoteur d'absorption
EP1245227A1 (fr) 2001-03-31 2002-10-02 Jagotec Ag Comprimé pharmaceutique flottant dans l'estomac destiné à la libération programmée du principe actif et procédé pour produire le matériel flottant compris dans le comprimé
WO2009157711A2 (fr) * 2008-06-24 2009-12-30 Park Eun-Seok Comprimé poreux gastro-rétentif et son procédé de préparation
FR2949061B1 (fr) * 2009-08-12 2013-04-19 Debregeas Et Associes Pharma Microgranules flottants
PT2719376E (pt) * 2012-10-12 2015-07-06 Omya Int Ag Sistemas de formulação e ministração de medicamentos gastrorretentivos e o seu método de preparação usando carbonato de cálcio funcionalizado
CN112236138B (zh) 2017-12-05 2024-05-31 赛诺维信制药公司 晶体形式及其制备方法
CA3084953A1 (fr) 2017-12-05 2019-06-13 Sunovion Pharmaceuticals Inc. Melanges non racemiques et leurs utilisations
JP7044649B2 (ja) * 2018-06-28 2022-03-30 株式会社ファンケル 胃内浮遊錠剤
SG11202113266YA (en) 2019-06-04 2021-12-30 Sunovion Pharmaceuticals Inc Modified release formulations and uses thereof
WO2023214018A1 (fr) 2022-05-06 2023-11-09 Galenix Innovations Composition à libération prolongée gonflable à rétention gastrique

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2415099A1 (fr) * 1978-01-20 1979-08-17 Ile De France Nouveaux derives de 4-amino-5-alkylsulfonyl ortho-anisamides, leurs procedes de preparation et leur application comme psychotropes
FR2554718B1 (fr) * 1983-11-14 1986-04-04 Ethypharm Sa Nouvelles formes galeniques du sulpiride utilisables par voie orale
FR2556964A1 (fr) * 1983-12-23 1985-06-28 Ile De France Nouvelles formes galeniques du sulpiride utilisables par voie orale
JPS62178518A (ja) * 1986-01-30 1987-08-05 Toho Yakuhin Kogyo Kk 新規持続性スルピリド錠剤
JPH0776172B2 (ja) * 1986-04-16 1995-08-16 藤沢薬品工業株式会社 マトリツクス錠
CA2039742A1 (fr) * 1990-04-23 1991-10-24 Andrew B. Dennis Comprimes pour ingredients pharmaceutiques sujets a problemes : composition et mode de preparation

Also Published As

Publication number Publication date
HUP0002455A3 (en) 2001-01-29
IL131995A0 (en) 2001-03-19
FR2762213A1 (fr) 1998-10-23
NO995039D0 (no) 1999-10-15
AR015586A1 (es) 2001-05-16
TNSN98049A1 (fr) 2005-03-15
NZ500288A (en) 2001-03-30
PE68199A1 (es) 1999-07-15
KR20010006353A (ko) 2001-01-26
MA26482A1 (fr) 2004-12-20
NO995039L (no) 1999-12-17
JO2017B1 (en) 1999-05-15
ZA983258B (en) 1998-10-19
WO1998047506A1 (fr) 1998-10-29
CN1252720A (zh) 2000-05-10
JP2001523241A (ja) 2001-11-20
AU737634B2 (en) 2001-08-23
AU7341698A (en) 1998-11-13
EP0983065A1 (fr) 2000-03-08
HUP0002455A2 (hu) 2000-12-28
CA2286081A1 (fr) 1998-10-29
PL336273A1 (en) 2000-06-19

Similar Documents

Publication Publication Date Title
IS4974A (is) Lyfjasamsetning á þrýstingsúðaformi
EE200000098A (et) Farmatseutiline kompositsioon piperidinoalkanooldekongestandi kombineerimiseks
ID23874A (id) Obat
DK0783302T3 (da) Lægemidler
FI973243A0 (fi) Uusi farmaseuttinen yhdistelmä
NO20021172L (no) Farmasöytisk sammensetning
FI955311A0 (fi) Farmaseuttinen koostumuspohja
NO994003L (no) Farmasoytisk blanding
DK1017392T3 (da) Lægemiddel
FR2762213B1 (fr) Composition pharmaceutique a retention gastrique
EE9900545A (et) Farmatseutiline kompositsioon
BR9600809A (pt) Medicamento
ID29294A (id) Komposisi farmasi
LV11727A (lv) Farmaceitiska kompozicija
MA26531A1 (fr) Composition pharmaceutique
ID25857A (id) Komposisi farmasi
FI955605A0 (fi) Aryloivia lääkkeitä
BR9605777A (pt) Composição farmacêutica
ID23531A (id) Komposisi farmasi
BR9605131A (pt) Composição farmacêutica
FR2772264B1 (fr) Pilulier
BR1100755A (pt) composição farmacêutica
ID21180A (id) Senyawa-senyawa farmasi
FI3163U1 (fi) Lääkesäiliö
FI3862U1 (fi) Geelimuotoinen farmaseuttinen valmiste

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse